medigraphic.com
ISSN 1995-9427 (Print)

2019, Number 2

<< Back Next >>

Invest Medicoquir 2019; 11 (2)

Intradiscal lumbar neurolysis with methylene blue as a treatment for discogenic pain

Benítez NPP, Carrazana AI, Torriente OD, Gutiérrez GM, Padrón M, Cabrera BY

Language: Spanish
References: 32
Page:
PDF size: 380.99 Kb.


ABSTRACT

Introduction. In order to evaluate the effectiveness of discolysis with methylene blue, to relieve discogenic lumbar pain, a therapeutic clinical trial was conducted at the Pain Clinic of the Surgical Medical Research Center, from January 2015 to January of 2018. Methods. The sample consisted of 50 patients, who were randomly assigned to two study groups: Group A: discolysis with methylene blue; Group B: discolysis with ozone. Both procedures were performed with local anesthesia and fluoroscopic control. To evaluate the clinical improvement, the group that obtained a greater number of patients was taken into account, in which a pain assessment of less than 2 and a Lattinen test equal to or less than 4 coincided; the adverse events that occurred were also evaluated. Results. In group A the number of patients who obtained clinical improvement was 24, while in group B it was 15 patients (p <0.001). The number of complications was lower in group A (p <0.001). Conclusions. Discolysis with methylene blue was more effective in relieving discogénico lumbar pain.


REFERENCES

  1. Geurts J. , Willems P, Kallewaard J. W. ,Van Kleef M., Dirksen C. The Impact of Chronic Discogenic Low Back Pain Costs and Patients’ Burden Hindawi Pain, Research and Management. Volume 2018, Article ID 4696180, 8 pages https://doi.org/10.1155/2018/4696180

  2. Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop.Clin.North.Am. 1991 Apr;22(2):181-87..

  3. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G,Bogduk N. The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine. 1994;19:801–806.

  4. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur.J.Pain. 2013;17:5-15.

  5. Derby R, Lettice JJ, Kula TA, Lee SH, Seo KS, Kim BJ. Single-level lumbar fusion in chronic discogenic low-back pain: psychological and emotional status as a predictor of outcome measured using the 36-item Short Form. J.Neurosurg.Spine. 2005;3:255–261.

  6. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes invertebral body marrow with MR imaging. Radiology.1988;166:193-199.

  7. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J,Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976).2001;26:1873-1878.

  8. Pearce RH, Thompson JP, Bebault GM, Flak B.Magnetic resonance imaging reflects the chemical changes of aging degeneration in the human intervertebral disk. J.Rheumatol.Suppl. 1991;27:42-43.

  9. Bogduk N. Provocation discography: lumbar disc stimulation. In: Bogduk N, ed. Practice Guidelines for Spinal Diagnostic and Treatment Procedures. San Francisco, CA:International Spine Intervention Society. 2004;20-46.

  10. Emch TM, Modic MT. Imaging of lumbar degenerative disk disease: history and current state. Skeletal Radiol. 2011;40:1175-1189.

  11. Andersson GB, Mekhail NA, Block JE.Treatment of intractable discogenic low back pain. A systematic review of spinal fusion and intradiscal electrothermal therapy (IDET). Pain Physician. 2006;9:237-248.

  12. Assietti R, Morosi M, Block JE. Intradiscal electrothermal therapy for symptomatic internal disc disruption: 24-month results and predictors of clinical success. J.Neurosurg.Spine. 2010;12:320-326.

  13. E. Jonsson, G. Olafsson, P. Fritzell et al., “Profile of low back pain: treatment and costs associated with patients referred to orthopaedic specialists in Sweden,” Spine. 2017 ,vol. 42, no. 17,pp. 1302–1310.

  14. Benítez Núñez P.P., González Guerra Y., Álvarez Monteagudo C. Valor diagnóstico de la discografía con ozono, en el dolor radicular provocado por hernias discales lumbares. Invest.Medicoquir. 2014;6(1):36-46.ISSN: 1995-9427, RNPS: 2162

  15. Benítez Núñez P.P., González Guerra Y., Álvarez Monteagudo C. Invest.Medicoquir. 2016;.8(1) 36-46.

  16. Expression of Pain-related Molecules: Glial Cell-derived Neurotropic Factor as a Key Factor. J.Neurosurg.Anesthesiol. 20011Oct;23(4): 329-34

  17. Geurts J., Kallewaard J., Kessels A., Willems P.C.et.al. Efficacy and cost-effectiveness of Intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial. Trials. 2015 Nov 21; 16:532 DOI 10.1186/s13063-015-1058-6.

  18. Gupta G, Radhakrishna M, Chankowsky J, Asenjo JF. Methylene blue in the treatment of discogenic low back pain. Pain Physician. 2012;15:333-338.

  19. Geurts J., Kallewaard J., Kessels A., Willems P.C.et.al. Efficacy and cost-effectiveness of Intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial. Trials. 2015 16: 532

  20. Bogduk N, Aprill C, Derby R. Lumbar discogenic pain:state-of-the-art review. Pain Med. 2013;14:813-36.

  21. Xiaohui G.,WenYuan D., LanZe L., SiDong .Intradiscal Methylene Blue Injection for Discogenic Low Back Pain: A Meta-Analysis. Pain Practice. 2019; 19, (1), 118–129

  22. Peng B, Zhang Y., Wu S., Xiaobing F. Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Eur.Spine.J. 2007; 16: 33–38 .

  23. Freemont AJ, Peacock TE, Goupille P, Hoyland JA,O’Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350:178-181

  24. Coppes MH, Marani E, Thomeer RT, Groen GJ. Innervation of “painful” lumbar discs. Spine. 1997;22:2342-2349.

  25. González-Escalada J.R, Camba A, Muriel C, Rodríguez M, Contreras D, de Barutell C. Validación del índice de Lattinen para la evaluación del paciente con dolor crónico. Rev.Soc.Esp. Dolor. 2012;19(4):181-188

  26. Levi DS, Horn S, Walko E. Intradiskal methylene blue treatment for diskogenic low back pain. Phys.Med.Rehabil. 2014;6:1030-1037

  27. Zhang XJ, Hao J, Hu ZM, Yang HT. Clinical evaluation and magnetic resonance imaging assessment of intradiscal methylene blue injection for the treatment of discogenic low back pain. Pain Physician. 2016;19:E1189–E1195.

  28. Kallewaard J, et al. A multicenter randomized controlled trial on the efficacy of intradiscal methylene blue injection for chronic discogenic low back pain. PAIN: January 03, 2019-Volume Articles in Press-Issue-p doi: 10.1097/j.pain.0000000000001475

  29. Xi M, Tong H C, Fahim D K, et al. Using Provocative Discography and Computed Tomography to Select Patients with Refractory Discogenic Low Back Pain for Lumbar Fusion Surgery.Cureus 2016 Feb; 8(2): e514. DOI 10.7759/cureus.514

  30. Morito T., Tomohiro H., Soraya N., Michihiro K. Discography aids definitive diagnosis of posterior epidural migration of lumbar disc fragments: case report and literature review BMC Musculoskeletal Disorders (2017) 18:151 DOI 10.1186/s12891-017-1516-2

  31. Derby R, Kim BJ, Lee SH, Chen Y, Seo KS, Aprill C. Comparison of discographic findings in asymptomatic subject discs and the negative discs of chronic LBP patients: can discography distinguish asymptomatic discs among morphologically abnormal discs? Spine.J. 2005;5:389-94.

  32. Manchikanti L., A Systematic Review and Best Evidence Synthesis of Effectiveness of Therapeutic Facet Joint Interventions in Managing Chronic Spinal Pain. Pain Physician. 2015; 18:E535-E582




2020     |     www.medigraphic.com